Lund University (ULUND) is one of the largest and oldest universities in Scandinavia. Participants rom ULUND are all members of the Lund University Diabetes Centre (LUDC), a Centre of Excellence funded in 2006 by the Swedish Research Council and one of the leading diabetes research centres in the world. PIs are located at the Clinical Research Centre of the University, in close connection to the Malmö University Hospital, creating the ideal setting for basic, clinical and translational research. The Centre, with >200 researchers and some of the best-characterised clinical studies in diabetes, covers all aspects of diabetes research, with special emphasis on diabetes genetics and epigenetics.

The main tasks in the project 

    ULUND has a great experience in collecting and arranging specific tissue repositories, epigenetic data acquisition, management and further implementation in clinical studies, which will provide valuable knowledge and serve as successful model for the employment of existing resource within LGDB in biomedical studies and planning future biobanking strategies. ULUND will provide well-tried strategies and approaches for analysis and interpretation of multi-omics epigenetic data, which have been already collected within the framework of the ongoing clinical trial. As a member of the Innovation board at Lund University Diabetes Centre Prof. Charlotte Ling will promote the development of innovation activities during the project.

    The LUDC has state-of-the-art facilities for whole-genome, exome, RNAsequencing and epigenetic studies; and a bioinformatics unit to meet the growing demand of large size data analyses. Modern, well‐equipped lab/animal facilities including molecular biology, biochemistry, histology, confocal imaging and functional studies. Conventional and barrier housing capacity, fully equipped for animal surgery; a transgenic facility; and assistance from trained animal care personnel and university veterinarians.